Astrazeneca Pharma India Q2 Results 2024:Astrazeneca Pharma India declared its Q2 results for 2024 on November 13, revealing a significant increase in revenue but a decline in profit compared to the previous year. The company’s revenue for the quarter stood at ₹408 crore, reflecting a 31.16% year-over-year growth, while profit decreased by 26.62% year-over-year to ₹38.43 crore.
In comparison to the previous quarter, Astrazeneca Pharma India saw a revenue growth of 5.28% and a remarkable profit increase of 425.95%. However, the increase in selling, general, and administrative expenses, which rose by 18.21% quarter-on-quarter and 12.86% year-over-year, contributed to the profit decline.
The operating income demonstrated a substantial improvement, increasing by 284.62% quarter-on-quarter, although it experienced a decline of 34.06% year-over-year. Earnings per share (EPS) for the quarter were reported at ₹15.37, down by 5.48% from the previous year.
In terms of stock performance, Astrazeneca Pharma India has delivered a -9.92% return in the last week, but has shown a positive trend with a 19.83% return over the past six months and a 22.55% year-to-date return. The company currently holds a market capitalization of ₹16,932.38 crore, with a 52-week high of ₹8,139 and a low of ₹4,600.7.
Astrazeneca Pharma India Financials
| Period | Q2 | Q1 | Q-o-Q Growth | Q2 | Y-o-Y Growth |
|---|---|---|---|---|---|
| Total Revenue | 408 | 387.52 | +5.28% | 311.07 | +31.16% |
| Selling/ General/ Admin Expenses Total | 92.57 | 78.31 | +18.21% | 82.02 | +12.86% |
| Depreciation/ Amortization | 9.32 | 3.91 | +138.36% | 3.67 | +153.68% |
| Total Operating Expense | 364.8 | 410.92 | -11.22% | 245.56 | +48.56% |
| Operating Income | 43.2 | -23.4 | +284.62% | 65.51 | -34.06% |
| Net Income Before Taxes | 51.03 | -15.16 | +436.61% | 73.38 | -30.46% |
| Net Income | 38.43 | -11.79 | +425.95% | 52.37 | -26.62% |
| Diluted Normalized EPS | 15.37 | 10.26 | +49.83% | 16.26 | -5.48% |
Disclaimer: This is an AI-generated live blog and has not been edited by LiveMint staff.
#Astrazeneca #Pharma #India #Results #Nov #profit #falls #YOY #profit #crore #revenue #crore #Company #Business #News
Astrazeneca Pharma India Q2 result, Astrazeneca Pharma India, Astrazeneca Pharma India Q2, Astrazeneca Pharma India Quarterly Result, Q2 Result
latest news today, news today, breaking news, latest news today, english news, internet news, top news, oxbig, oxbig news, oxbig news network, oxbig news today, news by oxbig, oxbig media, oxbig network, oxbig news media
HINDI NEWS
